Rapidly Changing Serous Detachment During BRAF and MEK Inhibitor Therapy

We report a case of rapidly changing serous retinal detachment (SRD) during melanoma therapy with a combination of encorafenib, a serine/threonine-protein kinase B-Raf (BRAF) inhibitor, and binimetinib, a mitogen-activated protein kinase (MEK) inhibitor. A 50-year-old woman with metastatic melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Agata, Chisato, Kitamoto, Kohdai, Ueda, Kohei, Azuma, Keiko, Inoue, Tatsuya, Obata, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761530/
https://www.ncbi.nlm.nih.gov/pubmed/35070538
http://dx.doi.org/10.7759/cureus.20491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761530/
https://www.ncbi.nlm.nih.gov/pubmed/35070538
http://dx.doi.org/10.7759/cureus.20491

Ejemplares similares